
Macrogenics Inc
MGNXNasdaqCIK 1125345HealthcareFiscal year ends Dec 31
Reports and events: 228 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-04-0317:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-24-000065 |
| 2024-03-0716:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-24-000061 |
| 2024-03-0716:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001125345-24-000060 |
| 2023-11-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-23-000125 |
| 2023-11-0616:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001125345-23-000124 |
| 2023-09-2216:42 ET | 8-K | 1.02 Termination of a material agreement | 0001125345-23-000113 |
| 2023-08-0916:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-23-000109 |
| 2023-08-0916:03 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001125345-23-000108 |
| 2023-06-0208:39 ET | 8-K | 5.07 Shareholder vote results | 0001125345-23-000081 |
| 2023-05-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-23-000077 |
| 2023-05-0916:04 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001125345-23-000076 |
| 2023-04-1716:01 ET | DEF 14A | Proxy statementPeriod 2023-05-31 | 0001125345-23-000067 |
| 2023-03-2416:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-23-000063 |
| 2023-03-1516:07 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001125345-23-000059 |
| 2023-03-1516:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-23-000058 |
| 2023-03-1016:38 ET | 8-K | 7.01 Regulation FD disclosure | 0001125345-23-000047 |
| 2023-03-0908:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-23-000045 |
| 2023-02-1418:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-23-000021 |
| 2023-01-0508:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125345-23-000011 |
| 2022-12-2116:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001125345-22-000113 |
| 2022-12-1616:28 ET | 8-K | 1.01 Entry into a material agreement | 0001125345-22-000111 |
| 2022-11-1818:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-22-000108 |
| 2022-11-0316:03 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001125345-22-000104 |
| 2022-11-0316:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-22-000103 |
| 2022-10-1716:22 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125345-22-000092 |
| 2022-08-0816:04 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001125345-22-000090 |
| 2022-08-0816:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-22-000089 |
| 2022-07-0817:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-22-000080 |
| 2022-05-2408:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125345-22-000070 |
| 2022-05-2317:01 ET | 8-K | 5.07 Shareholder vote results | 0001125345-22-000053 |
| 2022-05-0316:04 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001125345-22-000047 |
| 2022-05-0316:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-22-000046 |
| 2022-04-0816:06 ET | DEF 14A | Proxy statementPeriod 2022-05-19 | 0001125345-22-000039 |
| 2022-02-2416:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-22-000014 |
| 2022-02-2416:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001125345-22-000013 |
| 2022-01-0718:46 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001125345-22-000003 |
| 2021-11-0216:05 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001125345-21-000115 |
| 2021-11-0216:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-21-000114 |
| 2021-09-2716:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001125345-21-000107 |
| 2021-09-1616:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-21-000105 |
| 2021-09-0816:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-21-000103 |
| 2021-07-2916:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-21-000100 |
| 2021-07-2916:03 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001125345-21-000099 |
| 2021-06-1616:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-21-000087 |
| 2021-05-1817:01 ET | 8-K | 5.07 Shareholder vote results | 0001125345-21-000082 |
| 2021-04-2917:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-015000 |
| 2021-04-2916:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-21-000061 |
| 2021-04-2916:02 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001125345-21-000060 |
| 2021-04-0219:44 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001125345-21-000052 |
| 2021-04-0218:46 ET | DEF 14A | Proxy statementPeriod 2021-05-13 | 0001125345-21-000049 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:17 ET. Listed shows no prices and gives no investment advice.